Latest on Ultrasound Renal Denervation

Published: 22 June 2022

  • Views:

    Views Icon 7670
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 7 | Session 2 of 2
    TCT 2021 Symposium
    Chandan Devireddy, Ajay J Kirtane, Felix Mahfoud, Naomi Fisher
    Up Next
  • episode_image
    1h 4m 58s
    Part 7 | Session 1 ACC 2022 Symposium Michael Weber, Felix Mahfoud, Ajay J Kirtane, Michael Bloch
Average (ratings)
No ratings
Your rating

Overview

Ultrasound Renal Denervation (uRDN) is an innovative therapy option for the treatment of uncontrolled hypertension. uRDN therapy is delivered in a minimally invasive procedure that may lower high blood pressure by treating overactive renal nerves with ultrasound energy.

 

This page provides an overview of uRDN technology and the latest evidence from its associated RADIANCE clinical program.

 

The PARADISETM System is Limited to Investigational Use Only in the United States. Approved for distribution in CE mark countries only.
This educational content is supported by:

What you will learn:

  • How uRDN works and its potential benefits for patients suffering from uncontrolled hypertension
  • The clinical evidence supporting uRDN and its implications for the field of hypertension
  • The process for building a uRDN centre and therapy network

This page is designed for:

  • Interventional cardiologists
  • General cardiologists
  • Hypertension specialists
  • Nephrologists
  • Interventional radiologists

More from this programme

Part 4

RADIANCE II Pivotal Trial for Paradise Ultrasound Renal Denervation System in Patients With Hypertension

Part 6

Patient Perspective & Provider Referral Development

Understand patient preference and referral development

Part 7

Discussion With Experts

Faculty Biographies

Chandan Devireddy

Chandan Devireddy

Interventional Cardiologist and Associate Professor

Dr Devireddy is an Associate Professor of medicine of Interventional Cardiology at Emory University. He received his medical degree from the University of Michigan in 1998 and completed Internal Medicine training at Duke University in 2001. In 2005, he completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at Emory University. 

His focused expertise is on transcatheter structural heart solutions, minimally invasive techniques to lower blood pressure, and catheter based treatment of complex coronary, heart and vascular disease. 

View full profile
Ajay J Kirtane

Ajay J Kirtane

Professor of Clinical Medicine

Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.

 

In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…

View full profile
Felix Mahfoud

Felix Mahfoud

Associate Professor and Senior Physician

Prof Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Prof Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.

View full profile
Naomi Fisher

Naomi Fisher

Associate Professor

Dr Fisher is an endocrinologist at the Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. 

She has completed over two decades of clinical research at Harvard University, focusing on cardiovascular endocrinology.

She received her Bachelor of Arts degree in the History and Philosophy of Science from Princeton University, and her medical degree from the University of Pennsylvania.

View full profile